TrialHypertension (Dallas, Tex. : 1979)2012

Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients.

Prafull Raheja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.